The receptor pharmacology that underlies these studies is treated separately in the cagrilintide mechanism of action article, and the broader chemistry and classification are covered in the cagrilintide research overview
Cardiovasc Res 36:276281 Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
Hypogonadotropic Hypogonadism Models: HCG is frequently studied in male subjects with secondary (hypogonadotropic) hypogonadism, where the underlying deficit is insufficient gonadotropin signalling rather than primary testicular failure
Frequency depends on your individual needs and deficiency level